Sector Gamma As as of June 30, 2019
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 34 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 9.8 | $61M | 1.4M | 45.35 | |
| Abbott Laboratories (ABT) | 9.3 | $58M | 687k | 84.10 | |
| Boston Scientific Corporation (BSX) | 7.7 | $48M | 1.1M | 42.98 | |
| Baxter International (BAX) | 6.1 | $38M | 462k | 81.90 | |
| Gilead Sciences (GILD) | 4.8 | $30M | 445k | 67.56 | |
| NuVasive | 4.7 | $29M | 499k | 58.54 | |
| PerkinElmer (RVTY) | 4.7 | $29M | 300k | 96.34 | |
| Biogen Idec (BIIB) | 4.3 | $27M | 115k | 233.87 | |
| Incyte Corporation (INCY) | 4.3 | $27M | 314k | 84.96 | |
| Bio-Rad Laboratories (BIO) | 4.3 | $27M | 85k | 312.59 | |
| Agilent Technologies Inc C ommon (A) | 3.5 | $22M | 289k | 74.67 | |
| Anthem (ELV) | 3.3 | $21M | 73k | 282.22 | |
| Regeneron Pharmaceuticals (REGN) | 2.9 | $18M | 58k | 313.00 | |
| Humana (HUM) | 2.9 | $18M | 67k | 265.31 | |
| Qiagen Nv | 2.8 | $17M | 424k | 40.55 | |
| Takeda Pharmaceutical (TAK) | 2.3 | $14M | 796k | 17.70 | |
| Perrigo Company (PRGO) | 2.1 | $13M | 278k | 47.62 | |
| Bruker Corporation (BRKR) | 1.8 | $11M | 223k | 49.95 | |
| Patterson Companies (PDCO) | 1.7 | $11M | 469k | 22.90 | |
| Ptc Therapeutics I (PTCT) | 1.7 | $10M | 230k | 45.00 | |
| CVS Caremark Corporation (CVS) | 1.5 | $9.6M | 176k | 54.49 | |
| Mylan Nv | 1.5 | $9.6M | 505k | 19.04 | |
| Cardinal Health (CAH) | 1.5 | $9.3M | 197k | 47.10 | |
| Universal Health Services (UHS) | 1.4 | $8.4M | 65k | 130.39 | |
| Ionis Pharmaceuticals (IONS) | 1.4 | $8.5M | 132k | 64.27 | |
| Tenet Healthcare Corporation (THC) | 1.1 | $6.8M | 329k | 20.66 | |
| Clovis Oncology | 1.0 | $6.4M | 431k | 14.87 | |
| Elanco Animal Health (ELAN) | 1.0 | $6.3M | 185k | 33.80 | |
| McKesson Corporation (MCK) | 0.9 | $5.9M | 44k | 134.40 | |
| Portola Pharmaceuticals | 0.9 | $5.5M | 204k | 27.13 | |
| Alnylam Pharmaceuticals (ALNY) | 0.8 | $5.2M | 72k | 72.56 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $5.1M | 103k | 49.88 | |
| Ultragenyx Pharmaceutical (RARE) | 0.8 | $5.1M | 80k | 63.50 | |
| Sangamo Biosciences (SGMO) | 0.4 | $2.7M | 252k | 10.77 |
